Deepinder Goyal’s $54M brain-monitoring bet puts neurotech back in focus

Healthtech is moving beyond step counts and heart-rate tracking into more complex signals.

What happened

Deepinder Goyal returned with a $54M brain-monitoring bet after Zomato.

Why it matters

Brain monitoring sits at the intersection of diagnostics, wearables, deeptech, and consumer health. Founder quality makes the story more notable.

The bigger picture

Neurotech remains difficult, but the market could become important if companies can turn complex brain data into useful and trusted health products.